Company / Gross Profit per Share
Abbott Laboratories Gross Profit per Share History
FY2016-FY2018 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit per Share
$2.52
FY2018
5-year range
-
FY2016-FY2018
Trend
+37.1%
vs FY2017
Sector context
#88 of 99
Health Care
What the data says
Abbott Laboratories's gross profit per share of $2.52 is lower than 89% of companies in the Health Care sector (FY2018). Improved from $1.70 to $2.52 over the past 2 years.
Based on SEC 10-K filings.
2.52 in FY2018.
Improved from $1.70 to $2.52 over the past 2 years.
Health Care sector context is included.
Gross Profit per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 11% in Health CareTop 89% of 99This company $2.52 Sector average $13.98
▼
-82.0% below sector average
Key checks
Key Insights
- In FY2018, gross profit per share increased 37.1% year-over-year.
- Ranks #88 out of 99 companies in the Health Care sector.
Company context
Key Data Points
- Strong profit margin: 31.9%
- High earnings quality (cash-backed earnings)
- Strong return on equity: 27.4%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross Profit per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | $2.52 | +37.1% |
| FY2017 | $1.84 | +7.9% |
| FY2016 | $1.70 | +0.8% |
As of FY2018 · SEC 10-K · Updated Jun 30, 2026